PARSONS CORP
For the period ended Sep 30, 2026. Filed Oct 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
On August 9, 2021, the Company’s Board of Directors authorized the Company to acquire a number of shares of common stock having an aggregate market value of not greater than $100 million from time to time, commencing on August 12, 2021. The Board further amended this authorization in August 2022 to remove the prior expiration date and grant executive leadership the discretion to determine the price for such share repurchases. The Board further amended this authorization in March 2025 to increase and reset the repurchase capacity to $250 million. Repurchases made by the Company during the first quarter of 2025 were deducted from the reset capacity. In July 2026, the Board further amended this authorization to increase the repurchase capacity by an additional $250 million.
Under prior authorizations, the Company had repurchased shares with an aggregate market value of $79.7 million. The aggregate market value of shares of common stock the Company is authorized to acquire from prior authorizations, the March 2025 authorization, and July 2026 authorization as of September 30, 2026 was not greater than $579.7 million.
As of September 30, 2026, the Company has spent $314.7 million (which includes commissions paid of $0.1 million) repurchasing 5,709,204 shares of common stock at an average price of $55.12 per share.
Repurchased shares of common stock are retired and included in “Repurchases of common stock” in cash flows from financing activities in the Consolidated Statements of Cash Flows. The primary purpose of the Company’s share repurchase program is to reduce the dilutive effect of shares contributed under the Company’s ESOP and other stock benefit plans. The timing, amount and manner of share repurchases will be determined by the Company in its discretion and may depend upon market conditions and economic circumstances, availability of investment opportunities, the availability and costs of financing, the market price of the Company's common stock, other uses of capital and other factors.
The following table presents information with respect to repurchases of the Company's common stock for the three months ended September 30, 2026.
| Period · (a)Total number of shares purchased · (b)Average price paid per share (1) · (c)Total number of shares purchased as part of publicly announced plans or programs · (d)Maximum dollar value of shares that may yet be purchased under the plans or programs | ||||||
|---|---|---|---|---|---|---|
| July 1 to 31, 2026 | 462,000 | $43.51 | 462,000 | $304,909,855 | ||
| August 1 to 31, 2026 | 852,695 | (2) | $47.92 | 832,695 | 265,009,045 | |
| September 1 to 30, 2026 | - | $ | - | - | 265,009,045 | |
| Total | 1,314,695 | $46.37 | 1,294,695 | $265,009,045 | ||
(1)
Includes commissions in the calculation of average price per share.
(2)
Includes 20,000 shares purchased by affiliated purchasers through open market transactions. These transactions were not part of the Company’s share repurchase program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.